Search

Search Constraints

You searched for: Author/Creator Cohen, Jonathon B.

Search Results

1. A multicenter, real‐world analysis of primary central nervous system lymphoma in those with and without human immunodeficiency virus. Issue 3 (2nd June 2022)

3. A phase I study of rituximab and buparlisib in patients with relapsed or refractory indolent non-Hodgkin lymphoma. Issue 7 (7th June 2022)

4. A phase II study of bortezomib added to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone in patients with previously untreated indolent non‐Hodgkin's lymphoma. (7th August 2015)

6. Addition of Lenalidomide to R-CHOP Improves Outcomes in Newly Diagnosed Diffuse Large B-Cell Lymphoma in a Randomized Phase II US Intergroup Study ECOG-ACRIN E1412. Issue 12 (20th April 2021)

7. Comorbidities predict inferior outcomes in chronic lymphocytic leukemia treated with ibrutinib. Issue 15 (24th May 2018)

8. Complete response to induction therapy in patients with Myc‐positive and double‐hit non‐Hodgkin lymphoma is associated with prolonged progression‐free survival. Issue 11 (27th February 2014)

9. Complete response to induction therapy in patients with Myc‐positive and double‐hit non‐Hodgkin lymphoma is associated with prolonged progression‐free survival. Issue 11 (27th February 2014)

10. Complex karyotype in patients with mantle cell lymphoma predicts inferior survival and poor response to intensive induction therapy. Issue 11 (26th March 2018)